| scholarly article | Q13442814 |
| P356 | DOI | 10.1042/CS0380277 |
| P698 | PubMed publication ID | 5416155 |
| P2093 | author name string | Watts RW | |
| Gibbs DA | |||
| P433 | issue | 2 | |
| P921 | main subject | pyridoxine | Q423746 |
| primary hyperoxaluria | Q7243137 | ||
| P304 | page(s) | 277-286 | |
| P577 | publication date | 1970-02-01 | |
| P1433 | published in | Clinical science | Q27710468 |
| P1476 | title | The action of pyridoxine in primary hyperoxaluria | |
| P478 | volume | 38 |
| Q43123042 | A rare twist to a common problem. |
| Q67930631 | Control of hyperoxaluria with large doses of pyridoxine in patients with kidney stones |
| Q72805081 | Development of metaphylaxis in calcium urolithiasis: a restriction of conventional drug therapy |
| Q72887949 | Effect of combined supplementation of magnesium oxide and pyridoxine in calcium-oxalate stone formers |
| Q70967180 | Effect of pyridoxine on sodium glycolate-induced hyperoxaluria in rats |
| Q40015456 | Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay. |
| Q42001558 | Enzymological diagnosis of primary hyperoxaluria type 1 by measurement of hepatic alanine: glyoxylate aminotransferase activity |
| Q38791612 | Factors governing urinary tract stone disease |
| Q34302961 | Inborn errors of metabolism. Vitamin-responsive genetic disease |
| Q45866877 | Molecular therapy of primary hyperoxaluria |
| Q68905738 | Oxalate nephropathy in a Tibetan spaniel litter. A probable case of primary hyperoxaluria |
| Q39728357 | Oxalic acid and the hyperoxaluric syndromes |
| Q39897463 | Oxaluria. |
| Q35567868 | Primary and secondary hyperoxaluria: Understanding the enigma |
| Q70614494 | Primary hyperoxaluria |
| Q72823006 | Primary hyperoxaluria type 1: genotypic and phenotypic heterogeneity |
| Q37500313 | Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene. |
| Q61705700 | Primary oxalosis-an unusual cause of livedo reticularis |
| Q41642815 | Primary oxalosis: Clinical and biochemical response to high-dose pyridoxine therapy |
| Q38129886 | Protein homeostasis defects of alanine-glyoxylate aminotransferase: new therapeutic strategies in primary hyperoxaluria type I. |
| Q38229778 | Recent advances in the understanding, diagnosis and treatment of primary hyperoxaluria type 1. |
| Q36801261 | Selective renal transplantation in primary hyperoxaluria type 1. |
| Q36716285 | Successful renal transplantation in primary hyperoxaluria |
| Q69867396 | Successful treatment of infantile type I primary hyperoxaluria complicated by pyridoxine toxicity |
| Q72526724 | Successful treatment of primary hyperoxaluria in neonate |
| Q35977167 | Sustained pyridoxine response in primary hyperoxaluria type 1 recipients of kidney alone transplant |
| Q67249900 | The effect of endogenous l-phenyllactate on oxalate, glycolate, and glyoxylate excretion by phenylketonuric subjects |
| Q38105961 | Update on oxalate crystal disease |
| Q37621553 | Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40 years of practice |
| Q40096951 | Vitamin-Responsive Inborn Errors of Metabolism |
| Q69387606 | [Type I oxalosis in childhood--studies within the scope of terminal renal failure in the child] |
Search more.